Dr Rashida Karmali
Dr Rashida A Karmali completed a PhD in Biochemistry at Newcastle University in 1976. She is the Founder, CEO and President of Tactical Therapeutics, a clinical stage biotechnology company which is developing patented cancer drugs. The lead drug is in clinical trials in patients with glioblastomas.
After earning her Ph. D, she studied on the role of eicosanoids in cancer immunotherapy and autoimmune diseases with Dr Robert A. Good at the Memorial Sloan-Kettering Cancer Centre in New York City, and then at Rutgers University in New Brunswick, where she held a five-year academic position as Associate Professor. Her experience includes an extensive cancer research program described in more than 100 publications and she was featured on the cover of Cancer Research in December of 1997. She was awarded the Life Time Achievement Award by Marquis Who’s Who in 2017.
She obtained her JD at Rutgers University, Newark, and has run a solo law office on Wall Street since 2000. She specialises in technology and intellectual property rights law. She earned her MBA from Rutgers University, Newark.
“At Newcastle, my research required using facilities in multiple departments, creating opportunities for exchange of intelligence, networking and a knowledge base to build on.”